EcoDrugPlus

Integrin Alpha-5

Ensembl ID : ENSONIG00000016666
Gene Symbol: LOC100711983
4 Cross references
206 Possible Orthologues:

Integrin Alpha-Iib

Ensembl ID : ENSONIG00000009206
Gene Symbol: LOC100704409
2 Cross references
190 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSONIG00000016335
Gene Symbol: ITGB3B
1 Cross references
194 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSONIG00000000980
Gene Symbol: LOC100699105
4 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSONIG00000006861
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSONIG00000020239
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSONIG00000016141
Gene Symbol: ITGAV
4 Cross references
237 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSONIG00000003702
Gene Symbol: ITGB1
4 Cross references
213 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSONIG00000003317
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSONIG00000010860
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Integrin, Beta 1b

Ensembl ID : ENSONIG00000014982
Gene Symbol: ITGB1B
1 Cross references
228 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSONIG00000013667
Gene Symbol: ITGB5
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).